11/13
04:05 pm
eltx
Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Medium
Report
Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
11/7
04:05 pm
eltx
Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting
Medium
Report
Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting
10/31
08:30 am
eltx
Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit
Low
Report
Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit
10/16
08:30 am
eltx
Elicio Therapeutics Reports Inducement Grants
Medium
Report
Elicio Therapeutics Reports Inducement Grants
9/17
08:39 am
eltx
Elicio Therapeutics Reports Inducement Grants [Yahoo! Finance]
Low
Report
Elicio Therapeutics Reports Inducement Grants [Yahoo! Finance]
9/17
08:31 am
eltx
Elicio Therapeutics Reports Inducement Grants
Low
Report
Elicio Therapeutics Reports Inducement Grants
9/13
08:30 am
eltx
Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines
Low
Report
Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines
8/28
08:00 am
eltx
Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference